Search research articles
Contact Us
Filters
Showing results (91-100 of 114) with videos related to
Page
of 12
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 10, 2016
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents
Cheng Wang, Dong Ji, Jing Chen, et al.
Zhonghua Nei Ke Za Zhi
|
December 18, 2015
[The efficacy and prognostic predictors of different treatment courses with pegylated interferon α-2a and ribavirin combination in recurrent chronic hepatitis C patients]
Huiying Rao, Ruifeng Yang, Jia Shang, et al.
Infection and Drug Resistance
|
April 25, 2019
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
Xiaoning Wu, Jialing Zhou, Wen Xie, et al.
Clinical Epigenetics
|
September 3, 2020
Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study
Lixin Wang, Jianmin Luo, Guofeng Chen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 15, 2016
Early blood pressure lowering in patients with intracerebral haemorrhage and prior use of antithrombotic agents: pooled analysis of the INTERACT studies
Lili Song, Else Charlotte Sandset, Hisatomi Arima, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
August 4, 2015
[High sustained virological response to optimized therapy for refractory chronic hepatitis C treatment-na(i)ve patients: a multicenter randomized study]
Xinyue Chen, Jia Shang, Ruifeng Yang, et al.
Gastroenterology
|
March 15, 2023
Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma
Jing Chen, Kuai Liu, Yikai Luo, et al.
The American Journal of Gastroenterology
|
April 12, 2021
Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B
Dong Ji, Yan Chen, Qinghua Shang, et al.
Hepatology (Baltimore, Md.)
|
September 1, 2025
Early on-treatment LSM reliably predicts liver-related events in CHB patients with significant fibrosis and cirrhosis
Yameng Sun, Shuyan Chen, Xiaoqian Xu, et al.
Hepatology International
|
January 18, 2021
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy
Xiaoning Wu, Jialing Zhou, Yameng Sun, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 114) with videos related to
Sort By:
Page
of 12
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 10, 2016
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents
Cheng Wang, Dong Ji, Jing Chen, et al.
Zhonghua Nei Ke Za Zhi
|
December 18, 2015
[The efficacy and prognostic predictors of different treatment courses with pegylated interferon α-2a and ribavirin combination in recurrent chronic hepatitis C patients]
Huiying Rao, Ruifeng Yang, Jia Shang, et al.
Infection and Drug Resistance
|
April 25, 2019
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
Xiaoning Wu, Jialing Zhou, Wen Xie, et al.
Clinical Epigenetics
|
September 3, 2020
Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study
Lixin Wang, Jianmin Luo, Guofeng Chen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 15, 2016
Early blood pressure lowering in patients with intracerebral haemorrhage and prior use of antithrombotic agents: pooled analysis of the INTERACT studies
Lili Song, Else Charlotte Sandset, Hisatomi Arima, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
August 4, 2015
[High sustained virological response to optimized therapy for refractory chronic hepatitis C treatment-na(i)ve patients: a multicenter randomized study]
Xinyue Chen, Jia Shang, Ruifeng Yang, et al.
Gastroenterology
|
March 15, 2023
Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma
Jing Chen, Kuai Liu, Yikai Luo, et al.
The American Journal of Gastroenterology
|
April 12, 2021
Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B
Dong Ji, Yan Chen, Qinghua Shang, et al.
Hepatology (Baltimore, Md.)
|
September 1, 2025
Early on-treatment LSM reliably predicts liver-related events in CHB patients with significant fibrosis and cirrhosis
Yameng Sun, Shuyan Chen, Xiaoqian Xu, et al.
Hepatology International
|
January 18, 2021
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy
Xiaoning Wu, Jialing Zhou, Yameng Sun, et al.
Page
of 12